Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review

Peripheral Artery Disease

In: Cardiovascular, Respiratory, and Related Disorders. 3rd edition. Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2017 Nov 17. Chapter 14.
Review

Peripheral Artery Disease

Uchechukwu K A Sampson et al.

Excerpt

The term peripheral artery disease (PAD) classically encompasses the various diseases that affect noncardiac, nonintracranial arteries. The most common cause of PAD is atherosclerosis; less common causes include inflammatory disorders of the arterial wall (vasculitis) and noninflammatory arteriopathies, such as fibromuscular dysplasia (Kullo and Rooke 2016). Lower extremity PAD is a leading cause of atherosclerotic vascular morbidity and is only surpassed by coronary artery disease and stroke (Caro and others 2005; Criqui and others 1992; Dormandy and Rutherford 2000).

The global importance of PAD is rising because the number of people living with PAD has increased in the past decade; causes of the increase include aging populations and increased exposure to risk factors, particularly in low- and middle-income countries (LMICs) (Fowkes and others 2013). Consequently, assessing the need for coordinated and cost-effective responses to the burden of PAD is important.

This chapter discusses the global epidemiology of PAD based on recent evidence that provides updated comparisons of age- and gender-specific prevalence between high-income countries (HICs) and LMICs, risk factors for PAD in HICs and LMICs, and robust estimates of PAD deaths and the number of people living with PAD regionally and globally. The chapter provides insights into the implications of current PAD epidemiology for potential cost-effective approaches to prevention and treatment in LMICs.

PubMed Disclaimer

References

    1. Aboyans V, Criqui M H, Abraham P, Allison M A, Creager M A, and others. 2012. “Measurement and Interpretation of the Ankle-Brachial Index: A Scientific Statement from the American Heart Association.” Circulation 126 (24): 2890–909. - PubMed
    1. Adam D J, Beard J D, Cleveland T, Bell J, Bradbury A W, and others. 2005. “Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL): Multicentre, Randomised Controlled Trial.” The Lancet 366 (9501): 1925–34. - PubMed
    1. Bedenis R, Stewart M, Cleanthis M, Robless P, Mikhailidis D P, Stansby G. 2014. “Cilostazol for Intermittent Claudication.” Cochrane Database of Systematic Reviews 10: CD003748. doi:10.1002/14651858.CD003748.pub4. - PMC - PubMed
    1. Caro J, Migliaccio-Walle K, Ishak K J, Proskorovsky I. 2005. “The Morbidity and Mortality Following a Diagnosis of Peripheral Arterial Disease: Long-Term Follow-up of a Large Database.” BMC Cardiovascular Disorders 5: 14. - PMC - PubMed
    1. Criqui M H, Langer R D, Fronek A, Feigelson H S, Klauber M R, and others. 1992. “Mortality over a Period of 10 Years in Patients with Peripheral Arterial Disease.” New England Journal of Medicine 326 (6): 381–86. - PubMed